Controversial Crohn's disease risk factor clarified
Nature Immunology
April 7, 2009
Scientists may have discovered why a particular genetic mutation is associated with increased risk of Crohn's disease, a chronic inflammatory bowel disorder, as reported in a published study online in Nature Immunology this week.
Earlier studies showed that human cells bearing this mutation which interrupts the sequence of the gene encoding the pathogen detector NOD2 release lower amounts of the anti-inflammatory protein interleukin 10. However, mouse cells engineered to express a similar mutation produced normal amounts of interleukin 10.
A team led by Xiaojing Ma and colleagues now show that the human NOD2 mutant prevents activation of hnRNPA1, a protein required for expression of the human interleukin 10 gene. Notably, the human NOD2 mutant did not affect expression of the mouse interleukin 10 gene.
The findings provide insight into cellular events associated with Crohn's disease, and caution against relying solely on mouse models to investigate human immune disorders.
doi: 10.1038/ni.1722
Research highlights
-
Jun 29
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports